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This report describes the case of a 66-year-old previously
healthy man admitted to our institution for evaluation of
new-onset syncope. The patient had witnessed seizures after
admission associated with multiple periods of asystole on
telemetry. A temporary pacemaker was emergently placed
prior to transfer to the cardiac intensive care unit. An
electroencephalogram (EEG) demonstrated a seizure focus
at the right temporal lobe but a computed tomography (CT)
scan of the brain was unrevealing; magnetic resonance
imaging (MRI) was recommended. We describe the use of
an active ﬁxation right ventricular lead attached to an
external MRI-conditional pacemaker generator prior to
MRI scanning, which led to the diagnosis of anaplastic
astrocytoma.Case report
A 66-year-old previously healthy man with a past medical
history of hypertension and essential thrombocythemia
presented to our institution with recurrent, new-onset syn-
cope. The patient had recently returned to the United States
after spending several years living in Venezuela. He reported
that 2 days prior to admission he started experiencing
episodes of sudden loss of consciousness brieﬂy preceded
by nausea and lightheadedness, with each episode lasting 1–
2 minutes in duration. Between events he was asymptomatic.
Baseline electrocardiogram showed normal sinus rhythm and
was remarkable only for an interventricular conduction delayKEYWORDS Anaplastic astrocytoma; Asystole; Epilepsy; External temporary-
permanent pacemaker; MRI; Sinus arrest; Sudden unexpected death in
epilepsy (Heart Rhythm Case Reports 2016;2:296–299)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).without PR segment prolongation or any higher-grade
atrioventricular block. An echocardiogram demonstrated
normal biventricular function, impaired left ventricular
relaxation, and no signiﬁcant valvular disease. Admission
blood work was notable for a mildly elevated white blood
cell count at 13.9  103/μL and a normal hematocrit;
platelets were elevated to 616  103/μL, consistent with
his prior levels and his diagnosis of essential thrombocythe-
mia. Basic metabolic panel revealed normal electrolytes with
the exception of a mildly decreased bicarbonate at 21 mmol/
L with a normal creatinine. Lactic acid was elevated at 3.3
mmol/L. Cardiac biomarkers were negative.
He remained hemodynamically stable in the emergency
department and was admitted to a telemetry unit for
monitoring. Within 24 hours of admission, the patient had
multiple syncopal episodes while lying in bed. Review of
telemetry tracings from these events clearly demonstrated
immediately preceding sinus bradycardia followed by
multiple episodes of sinus arrest with asystole lasting 15–
20 seconds (Figure 1). Each episode spontaneously
resolved. Several hours later the events started to occur
approximately every 15–20 minutes. There was P-P pro-
longation for each event, followed by absence of a P wave
with no ventricular escape rhythm. The P-R interval did
not prolong. When en route to the electrophysiology
laboratory for emergent placement of a “temporary-perma-
nent” pacemaker, the patient had a generalized tonic-clonic
seizure requiring intubation, again associated with a pro-
longed period of asystole. A “temporary-permanent” exter-
nalized Medtronic (Adapta) pulse generator was connected
to an active ﬁxation right ventricular lead (Medtronic
CapSureFix Novus MRI-conditional 5076-58 cm; Med-
tronic, Minneapolis, MN). Excellent sensing and thresholds
were achieved without complications.
A subsequent EEG demonstrated localized ictal dis-
charges from the right temporal region. A brain CT scan
with contrast then demonstrated subtle edema in the posterior
right frontal lobe but was not considered diagnostic of a
speciﬁc etiology for this ﬁnding. MRI was recommended.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.01.012
KEY TEACHING POINTS
 Magnetic resonance imaging (MRI) is frequently
needed in patients with cardiovascular implantable
electronic devices, which historically have been a
contraindication to MRI.
 We describe the safe implantation of an external
MRI-compatible generator to expedite brain MRI in
the urgent workup of suspected intracranial
malignancy.
 The use of MR-conditional implantable electronic
devices can safely be used to facilitate MRI and is
particularly relevant for cases such as ours in which
computed tomography is unrevealing.
 Sinus bradycardia and sinus arrest are uncommon
manifestations of temporal lobe epilepsy.
 Risk stratiﬁcation of epileptic patients to
determine those at risk of bradyarrhythmias may be
clinically useful in preventing sudden unexpected
death in epilepsy, although more data are needed.
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not MR conditional, and MRI was institutionally declined.
The patient’s externally located generator was exchanged
for an MRI-conditional Medtronic Model ADSR01; con-
sultation with technical support indicated that the absentFigure 1 T2-weighted FLAIR sequence from the patient's brain magnetic
resonance imaging after external pacemaker placement demonstrates
hyperintense signal within the right temporal lobe inclusive of the
hippocampus, the right parahippocampal gyrus, and right cortical spinal
tract within the right internal capsule posterior limb and right cerebral
peduncle, and the bilateral corpus callosum splenium with extension to the
bilateral parietal lobes.atrial port would not be anticipated to result in problems with
MRI. The generator was programmed to the VOO mode
prior to uneventful brain MRI; post imaging, the generator
was programmed back to VVI mode. Appropriate-demand
ventricular pacing occurred after MRI, with no further
syncopal episodes.
The MRI revealed parenchymal T2-hyperintense signal
within the right medial temporal lobe, the right parahippo-
campal gyrus, the right cortical spinal tract within the right
internal capsule posterior limb and right cerebral peduncle,
and within the bilateral corpus callosum and splenium right
greater than left, primarily affecting white matter. Mild local
mass effect, concerning for a diffusely inﬁltrative mass, was
deﬁnitively visualized. There was additional ill-deﬁned
parenchymal T2-hyperintense signal noted within the bilat-
eral parietal lobes (Figure 2). A subsequent lumbar puncture
showed normal opening pressure, and the cerebrospinal ﬂuid
demonstrated a mildly increased total protein at 68 mg/dL
with negative oligoclonal banding. Extensive bacterial and
viral workup was negative. It was anticipated that further
bradycardic events were likely, and prior to discharge, a
dual-chamber Medtronic MRI-conditional pacemaker was
implanted.
A neurosurgical stereotactic brain biopsy of the right
temporal lobe lesion showed WHO grade III anaplastic
astrocytoma. The etiology of his bradycardia was thought
to be sinus arrest secondary to vagal nerve stimulation
mediated by temporal lobe epilepsy due to mass effect of
the anaplastic astrocytoma. The patient was scheduled to
undergo chemotherapy with temozolomide and stereotactic
brain radiation with serial-surveillance MRI studies.Discussion
Over the last 2 decades, MRI has emerged as the imaging
modality of choice for diagnosis of various soft tissue and
bony abnormalities. MRI is superior to CT for assessment of
intracranial neoplasms.1,2 Currently more than 2 million
Americans have a cardiovascular implantable electronic
device (CIED). It is estimated that between 50% and 75%
of these patients will have an indication for MRI during their
lifetime,3 for more or less compelling indications.
MRI is discouraged in patients with a “non-MRI-condi-
tional” CIED owing to 3 major safety concerns. The ﬁrst
relates to mechanical effects from potential magnetic ﬁeld–
induced force and torque that may result in device or lead
movement and dislocation or internal reed switch activation.
Second, electromagnetic effects related to the induction of
electrical current in the CIED leads in the case of implantable
cardioverter-deﬁbrillators may cause over- or undersensing
or could even capture the heart at the rate of the radio-
frequency coil owing to current induction, which may lead to
induction of malignant ventricular arrhythmias. Third,
repeated radiofrequency pulses used for signal induction in
MRI may lead to the induction of a powerful electrical ﬁeld
ampliﬁed at the lead tips, causing intense local heating effect
and subsequent tissue damage and edema. This may manifest
Figure 2 Progression from normal sinus rhythm to asystole during a seizure episode lasting for 20 seconds without alteration in electrical intervals or QRS
morphology.
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of arrhythmias.3,4
Recent innovations by CIED manufacturing companies
have led to the creation of “MRI-conditional” devices that
obviate all of the above issues. Current labeling of these
systems speciﬁes a waiting period of 6–9 weeks after implan-
tation of the CIED, based on the qualifying clinical studies.
Given the clinical necessity of MRI in our patient, it was
deemed that the urgent need to establish a diagnosis out-
weighed the potential risks of performing an MRI 3 days
after implantation of the “temporary-permanent” pacemaker.
There are institutional policies establishing eligibility for
MRI in patients with CIEDs, and many but not all institu-
tions are unwilling to perform MRI in patients with a CIED
that is not “MRI-conditional.” For example, Goldsher et al5
have previously described successful cervical MRI in a
patient several hours after implantation of a permanent
Medtronic Sigma 303 DR with Medtronic CapSureFix
5076 leads. Extensive discussions at our institution indicated
that MRI would not be considered without the presence of an
“MRI-conditional” lead and generator. However, imaging
would be considered with a “temporary-permanent” system
encompassing MRI-conditional components, even within the
initial postimplant window; any deleterious effects on
threshold would not be persistent with the temporary RV
lead. The Medtronic Advisa generator and Medtronic 5076
lead met these constraints.
Another interesting aspect of our case was the presenta-
tion of anaplastic astrocytoma as asystole and syncope.
Seizures are a frequent initial manifestation of brain neo-
plasms; however, presentation with asystole and syncope is
less commonly described. Sudden unexpected death in
epilepsy (SUDEP) occurs in approximately 1 in every1000 epileptic patients; although the underlying etiology of
SUDEP is poorly understood and thought to be multi-
factorial, it has been theorized that neurologic mediation of
cardiac arrhythmias plays a signiﬁcant role in the patho-
physiology of this syndrome.6–8
Sinus tachycardia is the most common arrhythmia asso-
ciated with ictal activity, occurring in up to 80% of seizures.
Less frequently, bradyarrhythmias have also been
described.8–12 One recent review of all available case reports
and case series of epileptic patients with documented
arrhythmias found 162 cases of ictal and postictal arrhyth-
mias in patients undergoing video EEG monitoring.13 One
hundred and three of these cases were identiﬁed as ictal
asystole (generally deﬁned as R-R interval 43–4 seconds
with correlating seizure activity on video EEG). The overall
prevalence of ictal asystole was 0.177% in all patients
admitted for routine video EEG monitoring and 0.318% in
patients with known refractory epilepsy. The mean duration
of ictal asystole was 20 seconds (range, 3–96 seconds). The
authors also found 13 documented cases of postictal asystole
with mean duration of 30 seconds. Peri-ictal asystole was
self-limited in all cases except 1, in which CPR was started
after 44 seconds of sinus arrest. Ictal bradycardia without
asystole (25 cases) and second- and third-degree atrioven-
tricular conduction block (11 cases) were also rare ﬁndings
in this review.13 Comorbid cardiovascular conditions and
medication history were not consistently well documented,
making interpretation of this data somewhat difﬁcult.
The exact mechanism of ictal-associated asystole is
unknown, but has been hypothesized to be rooted in a
vagally mediated response related to stimulation of the
insular cortex of the temporal lobe. A small study involving
stimulation of the insular cortex of 5 epileptic patients
299McGuinn et al MRI-Safe Temporary-Permanent Pacemakerundergoing temporal lobectomy for refractory seizures
demonstrated resultant bradyarrythmias;14 the temporal lobe
has been documented as a frequent focus of seizures in cases
of epilepsy-mediated bradycardia. It is thought that peri-ictal
bradycardias promote SUDEP, given concomitant respira-
tory depression and hypoxemia, which is independently
arrhythmogenic.7 These ﬁndings raise the important question
of how to risk-stratify patients with epilepsy-mediated
bradycardia who may potentially be at risk for an asystolic
event, for consideration of outpatient cardiac monitoring and
potential pacemaker implantation.
As far as we know, this is the ﬁrst case in which MRI was
performed in a patient after implantation of a “temporary-
permanent MRI-conditional” pacing system. We note that
this is an out-of-label use, since the system is approved for
permanent implantation and the current labeling and qualify-
ing studies did not include scanning immediately after
implantation. The use of an MRI-conditional system in this
circumstance, as illustrated in this case report, assuaged
concerns about MRI and accordingly facilitated the timely
diagnosis of this patient’s underlying malignancy with
therapeutic implications. The concerns about MRI with
non-MRI-conditional components are almost certainly not
institutionally unique. This report highlights the feasibility of
an MRI-conditional pacemaker system in patients presenting
with sudden unexplained neurological symptoms where MRI
is essential for establishing a diagnosis.
Acknowledgments
Thank you to Ty Abel, MD, PhD, in the Department of
Pathology, Microbiology, and Immunology at VanderbiltMedical Center for providing the histopathology slides for
this case.References
1. Johnson PC, Hunt SJ, Drayer BP. Human cerebral gliomas: correlation of
postmortem MR imaging and neuropathologic ﬁndings. Radiology 1989;170:
211–217.
2. Zimmerman RA. Imaging of adult central nervous system primary malignant
gliomas. Staging and follow-up. Cancer 1991;67:1278–1283.
3. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and
deﬁbrillator patients. Pacing Clin Electrophysiol 2005;28:326–328.
4. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic
resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol
2004;43:1315–1324.
5. Goldsher D, Jahshan S, Roguin A. Successful cervical MR scan in a patient
several hours after pacemaker implantation. Pacing Clin Electrophysiol 2009;32:
1355–1356.
6. Devinsky O. Sudden, unexpected death in epilepsy. N Engl J Med 2011;365:
1801–1811.
7. Shorvon S, Tomson T. Sudden unexpected death in epilepsy. Lancet 2011;378:
2028–2038.
8. Rajakulendran S, Nashef L. Postictal generalized EEG suppression and SUDEP:
a review. J Clin Neurophysiol 2015;32:14–20.
9. Schuele SU, Bermeo AC, Alexopoulos AV, Locatelli ER, Burgess RC, Dinner
DS, Foldvary-Schaefer N. Video-electrographic and clinical features in patients
with ictal asystole. Neurology 2007;69:434–441.
10. Schuele SU, Bermeo AC, Locatelli E, Burgess RC, Luders HO. Ictal asystole: a
benign condition? Epilepsia 2008;49:168–171.
11. Rugg-Gunn FJ, Simister RJ, Squirrell M, Holdright DR, Duncan JS. Cardiac
arrhythmias in focal epilepsy: a prospective long-term study. Lancet 2004;364:
2212–2219.
12. Zijlmans M, Flanagan D, Gotman J. Heart rate changes and ECG abnormalities
during epileptic seizures: prevalence and deﬁnition of an objective clinical sign.
Epilepsia 2002;43:847–854.
13. van der Lende M, Surges R, Sander JW, Thijs RD. Cardiac arrhythmias during or
after epileptic seizures. J Neurol Neurosurg Psychiatry 2016;87(1):69–74.
14. Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of
human insular cortex stimulation. Neurology 1992;42:1727–1732.
